Fri, April 16, 2021
Thu, April 15, 2021
Wed, April 14, 2021
Tue, April 13, 2021
Mon, April 12, 2021
Fri, April 9, 2021
Thu, April 8, 2021

Matthew Harrison Maintained (TSHA) at Buy with Increased Target to $43 on, Apr 13th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-43-on-apr-13th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Buy with Increased Target from $30 to $43 on, Apr 13th, 2021.

Matthew has made no other calls on TSHA in the last 4 months.



There are 2 other peers that have a rating on TSHA. Out of the 2 peers that are also analyzing TSHA, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Raju Prasad of "William Blair" Initiated at Buy and Held Target at $46 on, Wednesday, February 24th, 2021
  • Kevin DeGeeter of "Oppenheimer" Initiated at Buy on, Tuesday, January 5th, 2021

Publication Contributing Sources